Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Ημερομηνία
2020Γλώσσα
en
Λέξη-κλειδί
Επιτομή
[No abstract available]
Collections
Related items
Showing items related by title, author, creator and subject.
-
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
Lagoumintzis G., Chasapis C.T., Alexandris N., Kouretas D., Tzartos S., Eliopoulos E., Farsalinos K., Poulas K. (2021)SARS-CoV-2 is the coronavirus that originated in Wuhan in December 2019 and has spread globally. Studies have shown that smokers are less likely to be diagnosed with or be hospitalized for COVID-19 but, once hospitalized, ... -
Nicotinic cholinergic system and covid-19: In silico identification of an interaction between sars-cov-2 and nicotinic receptors with potential therapeutic targeting implications
Farsalinos K., Eliopoulos E., Leonidas D.D., Papadopoulos G.E., Tzartos S., Poulas K. (2020)While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell entry, it is important to examine other potential interactions between the virus and other cell receptors. Based on the clinical observation ... -
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
Karagiorgou K., Dandoulaki M., Mantegazza R., Andreetta F., Furlan R., Lindstrom J., Zisimopoulou P., Chroni E., Kokotis P., Anagnostou E., Tzanetakos D., Breza M., Katsarou Z., Amoiridis G., Mastorodemos V., Bregianni M., Bonakis A., Tsivgoulis G., Voumvourakis K., Tzartos S., Tzartos J. (2022)BACKGROUND AND OBJECTIVES: Autoantibodies against α3-subunit-containing nicotinic acetylcholine receptors (α3-nAChRs), usually measured by radioimmunoprecipitation assay (RIPA), are detected in patients with autoimmune ...